Hideyuki Ujiie

3.8k total citations
130 papers, 1.8k citations indexed

About

Hideyuki Ujiie is a scholar working on Pathology and Forensic Medicine, Genetics and Rheumatology. According to data from OpenAlex, Hideyuki Ujiie has authored 130 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Pathology and Forensic Medicine, 58 papers in Genetics and 58 papers in Rheumatology. Recurrent topics in Hideyuki Ujiie's work include Autoimmune Bullous Skin Diseases (71 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (57 papers) and Urticaria and Related Conditions (52 papers). Hideyuki Ujiie is often cited by papers focused on Autoimmune Bullous Skin Diseases (71 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (57 papers) and Urticaria and Related Conditions (52 papers). Hideyuki Ujiie collaborates with scholars based in Japan, Germany and United States. Hideyuki Ujiie's co-authors include Hiroshi Shimizu, Wataru Nishie, Ken Natsuga, Hiroaki Iwata, Kentaro Izumi, Satoru Shinkuma, Daisuke Sawamura, Akihiko Shibaki, Hideki Nakamura and Jun Yamagami and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and Analytical Chemistry.

In The Last Decade

Hideyuki Ujiie

114 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hideyuki Ujiie Japan 23 1.2k 1.0k 950 261 187 130 1.8k
Hiroaki Iwata Japan 23 1.2k 1.0× 963 1.0× 892 0.9× 210 0.8× 152 0.8× 102 1.8k
C. Prost‐Squarcioni France 20 753 0.6× 583 0.6× 531 0.6× 160 0.6× 145 0.8× 50 1.2k
Akihiko Shibaki Japan 24 666 0.6× 484 0.5× 573 0.6× 281 1.1× 228 1.2× 43 1.6k
Ken Natsuga Japan 26 891 0.7× 665 0.7× 647 0.7× 543 2.1× 650 3.5× 105 2.1k
Ken Ishii Japan 24 1.6k 1.3× 1.1k 1.1× 1.1k 1.1× 186 0.7× 141 0.8× 38 2.1k
Wataru Nishie Japan 34 1.9k 1.6× 1.6k 1.5× 1.4k 1.5× 604 2.3× 827 4.4× 126 3.3k
Hideo Yaoita Japan 22 1.1k 0.9× 545 0.5× 603 0.6× 345 1.3× 600 3.2× 88 2.0k
Johannes S. Kern Germany 24 814 0.7× 360 0.4× 336 0.4× 430 1.6× 975 5.2× 83 2.0k
Ana María Abreu Vélez United States 16 553 0.5× 333 0.3× 337 0.4× 83 0.3× 82 0.4× 104 928
Loı̈c Vaillant France 18 893 0.7× 524 0.5× 756 0.8× 94 0.4× 34 0.2× 44 1.8k

Countries citing papers authored by Hideyuki Ujiie

Since Specialization
Citations

This map shows the geographic impact of Hideyuki Ujiie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideyuki Ujiie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideyuki Ujiie more than expected).

Fields of papers citing papers by Hideyuki Ujiie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideyuki Ujiie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideyuki Ujiie. The network helps show where Hideyuki Ujiie may publish in the future.

Co-authorship network of co-authors of Hideyuki Ujiie

This figure shows the co-authorship network connecting the top 25 collaborators of Hideyuki Ujiie. A scholar is included among the top collaborators of Hideyuki Ujiie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideyuki Ujiie. Hideyuki Ujiie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mai, Yosuke, et al.. (2025). Identification of distinct epitopes in dipeptidyl peptidase-4 inhibitor–associated bullous pemphigoid. Science Advances. 11(31). eadv9423–eadv9423.
2.
Mai, Yosuke, Yasuaki Kobayashi, Hiroyuki Kitahata, et al.. (2024). Patterning in stratified epithelia depends on cell–cell adhesion. Life Science Alliance. 7(9). e202402893–e202402893.
3.
Yanagi, Teruki, Takuya Maeda, Hiroshi Nishihara, et al.. (2024). Establishment of a trastuzumab-resistant extramammary Paget disease model: loss of PTEN as a potential mechanism. British Journal of Cancer. 131(5). 944–953. 2 indexed citations
4.
Muramatsu, Ken, et al.. (2024). Improvement of acute phase symptoms of pemphigus foliaceus with spesolimab. JAAD Case Reports. 55. 40–44. 1 indexed citations
5.
Yanagi, Teruki, Takuya Maeda, Hiroshi Nishihara, et al.. (2023). Eribulin inhibits growth of cutaneous squamous cell carcinoma cell lines and a novel patient-derived xenograft. Scientific Reports. 13(1). 8650–8650. 5 indexed citations
6.
Ozeki, Takeshi, Ken Muramatsu, Kentaro Izumi, et al.. (2023). Association of Genetic Variants of HLA-DQA1 with Bullous Pemphigoid Induced by Dipeptidyl Peptidase-4 Inhibitors. Journal of Investigative Dermatology. 143(11). 2219–2225.e5. 4 indexed citations
7.
Imafuku, Keisuke, Sho Nakakubo, Sumio Iwasaki, et al.. (2023). Pseudotumor of the skin due to Mycobacterium genavense. International Journal of Infectious Diseases. 134. 88–90. 1 indexed citations
8.
Kato, Masaru, Hideyuki Ujiie, Ryo Hisada, et al.. (2022). Beneficial effects of nintedanib on cardiomyopathy in patients with systemic sclerosis: a pilot study. Lara D. Veeken. 62(7). 2550–2555. 12 indexed citations
9.
Yamagami, Jun, Takeru Funakoshi, Ryo Tanaka, et al.. (2022). Rituximab therapy for intractable pemphigus: A multicenter, open‐label, single‐arm, prospective study of 20 Japanese patients. The Journal of Dermatology. 50(2). 175–182. 4 indexed citations
10.
Maeda, Takuya, et al.. (2022). Adjuvant nivolumab therapy may not improve disease‐free survival in resected acral lentiginous melanoma patients: A retrospective case series. Dermatologic Therapy. 35(11). e15817–e15817. 4 indexed citations
11.
Iwata, Hiroaki, Yosuke Mai, Keisuke Imafuku, et al.. (2021). Super‐resolution imaging detects BP180 autoantigen in immunoglobulin M pemphigoid. The Journal of Dermatology. 49(3). 374–378. 8 indexed citations
12.
Fujimura, Y, Mika Watanabe, Yasuaki Kobayashi, et al.. (2021). Hair follicle stem cell progeny heal blisters while pausing skin development. EMBO Reports. 22(7). e50882–e50882. 9 indexed citations
13.
Iwata, Hiroaki, et al.. (2021). Clinical characteristics and outcomes of bullous pemphigoid patients with versus without oral prednisolone treatment. The Journal of Dermatology. 48(4). 502–510. 5 indexed citations
14.
Ujiie, Hideyuki, et al.. (2020). Prevalence of infectious diseases in patients with autoimmune blistering diseases. The Journal of Dermatology. 47(4). 378–384. 3 indexed citations
15.
Ujiie, Hideyuki, et al.. (2020). Epitope spreading possibly from BP230 to the NC16A domain of BP180 preceding disease progression in bullous pemphigoid. The Journal of Dermatology. 47(7). e255–e257. 3 indexed citations
16.
Ujiie, Hideyuki, et al.. (2018). Clinical and immunological features of pemphigus relapse. British Journal of Dermatology. 180(6). 1498–1505. 18 indexed citations
17.
Iwata, Hiroaki & Hideyuki Ujiie. (2017). Complement‐independent blistering mechanisms in bullous pemphigoid. Experimental Dermatology. 26(12). 1235–1239. 22 indexed citations
18.
Li, Qiang, Tianwen Gao, Heather A. Long, & Hideyuki Ujiie. (2010). Clearance of a Thick Invasive Squamous Cell Carcinoma After Multiple Treatments with Topical Photodynamic Therapy. Photomedicine and Laser Surgery. 28(5). 703–706. 17 indexed citations
19.
Ujiie, Hideyuki, Akihiko Shibaki, Wataru Nishie, et al.. (2010). A Novel Active Mouse Model for Bullous Pemphigoid Targeting Humanized Pathogenic Antigen. The Journal of Immunology. 184(4). 2166–2174. 61 indexed citations
20.
Nishie, Wataru, Daisuke Sawamura, Ken Natsuga, et al.. (2009). A Novel Humanized Neonatal Autoimmune Blistering Skin Disease Model Induced by Maternally Transferred Antibodies. The Journal of Immunology. 183(6). 4088–4093. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hiroaki Iwata Breakdown of academic impact, for papers by C. Prost‐Squarcioni Breakdown of academic impact, for papers by Akihiko Shibaki Breakdown of academic impact, for papers by Ken Natsuga Breakdown of academic impact, for papers by Ken Ishii Breakdown of academic impact, for papers by Wataru Nishie Breakdown of academic impact, for papers by Hideo Yaoita Breakdown of academic impact, for papers by Johannes S. Kern Breakdown of academic impact, for papers by Ana María Abreu Vélez Breakdown of academic impact, for papers by Loı̈c Vaillant
Rankless by CCL
2026